Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibronectin type III domain-containing protein 11 (FNDC11)
- Target
- FNDC11
- Molecular classification
- Other (Fibronectin type III domain-containing protein family)
01
Overview
Fibronectin type III domain-containing protein 11 (FNDC11) is a member of the FNDC family, characterized by the presence of a conserved fibronectin type III domain, a motif involved in protein-protein interactions and common in many extracellular matrix and adhesion proteins[1][3][7]. FNDC11 is a protein-coding gene broadly conserved across vertebrates. While several FNDC proteins play roles in processes such as cell adhesion, migration, and tissue development, there is currently little published data or experimental evidence regarding FNDC11’s specific molecular function, expression profile in disease, or suitability as a therapeutic target in humans[1][3][7]. Databases suggest expression in a wide range of tissues, but without clear associations to signal transduction, disease pathophysiology, or validated drug interactions[2][3][4]. As such, FNDC11 is not currently recognized as a canonical therapeutic target or biomarker.
- Other names
- C20orf195MGC5356fibronectin type III domain containing 11FND11FNDC11
02
Biological functions
Unknown, insufficient evidence for specific biological functions in humans
03
Disease associations
Other (potentially associated diseases include eosinophilic variant of chromophobe renal cell carcinoma and glycogen storage disease III, but evidence is limited and not target-specific)
Beyond the preview
Go deeper on Fibronectin type III domain-containing protein 11 (FNDC11).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fibronectin type III domain-containing protein 11 (FNDC11).